Harriet De Wit to Genetic Variation
This is a "connection" page, showing publications Harriet De Wit has written about Genetic Variation.
Connection Strength
0.403
-
Translational genetic approaches to substance use disorders: bridging the gap between mice and humans. Hum Genet. 2012 Jun; 131(6):931-9.
Score: 0.241
-
Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):5968-73.
Score: 0.071
-
Further evidence of association between amphetamine response and SLC6A2 gene variants. Psychopharmacology (Berl). 2009 Oct; 206(3):501-11.
Score: 0.052
-
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2008 Nov; 33(12):2791-800.
Score: 0.012
-
Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry. 2007 Jun 01; 61(11):1296-305.
Score: 0.011
-
Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 05; 139B(1):42-4.
Score: 0.010
-
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2003 Sep; 28(9):1694-702.
Score: 0.008